Sumitomo Mitsui Trust Group
CDLX icon

Sumitomo Mitsui Trust Group’s Cardlytics CDLX Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-362
Closed -$253K – 1103
2020
Q2 		$253K Buy
+362
New +$209K ﹤0.01% 1071

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group's CDLX Position: Q3 2020 in Review

Sumitomo Mitsui Trust Group sold out of Cardlytics (CDLX) in Q3 2020, closing a stake of 362 shares — an estimated $253K sold.

Sumitomo Mitsui Trust Group first reported a position in CDLX in Q2 2020 and held it in 1 quarter. The position peaked at $253K in Q2 2020. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2020.

  • Sumitomo Mitsui Trust Group reported no remaining Cardlytics position as of Q3 2020 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 362 Cardlytics shares in Q3 2020, an estimated $253K.
  • Sumitomo Mitsui Trust Group first reported a position in Cardlytics in Q2 2020 and held it in 1 quarter.
  • Sumitomo Mitsui Trust Group's Cardlytics position peaked at $253K in Q2 2020.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2020.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2020, filed 30 Oct 2020.